Anti-viral activity of compounds from Agrimonia pilosa and Galla rhois extract mixture.

[1]  P. Hu,et al.  A systematic review with meta-analysis: Is ribavirin necessary in sofosbuvir-based direct-acting antiviral therapies for patients with HCV recurrence after liver transplantation? , 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

[2]  Jun Chang,et al.  Recombinant baculovirus-based vaccine expressing M2 protein induces protective CD8+ T-cell immunity against respiratory syncytial virus infection , 2017, Journal of Microbiology.

[3]  A. Siddiqui,et al.  Ginsenoside Rg3 restores hepatitis C virus–induced aberrant mitochondrial dynamics and inhibits virus propagation , 2017, Hepatology.

[4]  Joseph K. Lim,et al.  Developing therapies to treat hepatitis C infection in post-liver transplant recipients , 2017, Expert opinion on pharmacotherapy.

[5]  I. Jacobson,et al.  Hepatitis C—A clinical review , 2016, Journal of medical virology.

[6]  N. Hayashi,et al.  JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2 , 2016, Hepatology research : the official journal of the Japan Society of Hepatology.

[7]  J. Niu,et al.  Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A , 2015, Cellular and Molecular Immunology.

[8]  R. Poole.  Daclatasvir + Asunaprevir: First Global Approval , 2014, Drugs.

[9]  Ralf Bartenschlager,et al.  The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection , 2013, Nature Reviews Microbiology.

[10]  R. Fontana,et al.  Immunological dysfunction during or after antiviral therapy for recurrent hepatitis C reduces graft survival , 2013, Hepatology International.

[11]  N. Selzner,et al.  Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients. , 2011, Journal of hepatology.

[12]  San-Jun Han,et al.  Antimicrobial Effects of the Extract of Galla rhois on the Long-term Swine Clinical Trial , 2011 .

[13]  B. Seong,et al.  Broad‐spectrum antiviral effect of Agrimonia pilosa extract on influenza viruses , 2010, Microbiology and immunology.

[14]  N. Nakamura,et al.  Inhibitory effects of Korean plants on HIV‐1 activities , 2001, Phytotherapy research : PTR.

[15]  G. Fattovich,et al.  Hemolytic anemia induced by ribavirin therapy in patients with chronic hepatitis C virus infection: Role of membrane oxidative damage , 2000, Hepatology.